SKI Market

A+| A| A-|

Indian Indices

Sensex

78,520.30 26.76
( 0.03%)

Global Indices

Nasdaq

49,464.98 -3.46
(-0.01%)

Dow Jones

7,130.75 -16.31
(-0.23%)

Hang Seng

58,818.22 342.32
(0.59%)

Nikkei 225

10,604.22 -63.41
(-0.59%)

Forex

USD-INR

93.19 -0.12
(-0.13%)

EUR-INR

109.85 -0.18
(-0.16%)

GBP-INR

126.25 -0.31
(-0.25%)

JPY-INR

0.59 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ipca Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524494

INE571A01038

291.9817605

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IPCALAB

37.09

37256.46

EPS(TTM)

Face Value()

Div & Yield %

39.59

0.27

Back

Emmessar Biotech & Nutrition standalone net profit declines 60.71% in the September 2025 quarter

Nov 12,2025

Net profit of Emmessar Biotech & Nutrition declined 60.71% to Rs 0.11 crore in the quarter ended September 2025 as against Rs 0.28 crore during the previous quarter ended September 2024. Sales declined 73.53% to Rs 0.09 crore in the quarter ended September 2025 as against Rs 0.34 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.09	0.34	-74
OPM %	-411.11	-23.53	-
PBDT	0.17	0.43	-60
PBT	0.14	0.41	-66
NP	0.11	0.28	-61

78,520.30 26.76 ( 0.03%)

49,464.98 -3.46 (-0.01%)

7,130.75 -16.31 (-0.23%)

58,818.22 342.32 (0.59%)

10,604.22 -63.41 (-0.59%)

93.19 -0.12 (-0.13%)

109.85 -0.18 (-0.16%)

126.25 -0.31 (-0.25%)

0.59 0.00 (-0.15%)